Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    vs5584
Show Display Options
Rank Status Study
1 Recruiting Phase I Dose Escalation Study of VS-5584 in Subjects With Advanced Non-Hematologic Malignancies or Lymphoma
Conditions: Non Hematologic Cancers;   Metastatic Cancer;   Lymphoma
Intervention: Drug: VS-5584
2 Active, not recruiting A Phase 1 Dose Escalation Study of VS-5584 Administered in Combination With VS-6063, in Subjects With Relapsed Malignant Mesothelioma
Condition: Relapsed Malignant Mesothelioma
Intervention: Drug: VS-5584 and VS-6063

Indicates status has not been verified in more than two years